Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

migalastat

- PMLiVE

Brexit migration measures threaten UK clinical research

Calls for less restrictive working visa requirements

- PMLiVE

Blockchain pilot for electronic health records kicks off in UK

MyClinic.com allows users to remotely consult a doctor

- PMLiVE

Hancock says UK genome service is now ‘rolling out’

Health secretary also announces a £240m social care boost

- PMLiVE

Bayer to challenge Avastin legal ruling

Both sides claim to be acting in patients' best interest

- PMLiVE

Alnylam seeks fast-track filing with biomarker data

Early filing reflects FDA desire for faster approvals

- PMLiVE

NHS wins legal fight with pharma over off-label Avastin

Industry criticises judgement - fearful of 'undermining regulation' as well as big earning products

- PMLiVE

UK pharma to work with innovation network on NHS uptake

The five year deal covers AI, genomics, personalised medicine and more

- PMLiVE

Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma

Proactive adjuvant treatment could extend melanoma patient lives

- PMLiVE

Controversy grows around GP at Hand service after minister’s endorsement

Hancock says service should be rolled out across England

Roche Basel Switzerland

Dismay as NICE rejects Roche’s MS drug Ocrevus

Treatment deemed too costly to treat primary progressive MS

- PMLiVE

NICE turns down Opdivo for adjuvant melanoma therapy

BMS drug currently only licensed treatment in this setting

- PMLiVE

Outdated health service IT ‘cost lives’ says health secretary

Matt Hancock outlines plan for a “tech-driven” NHS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links